Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVI Global Trust Regulatory News (AGT)

Share Price Information for AVI Global Trust (AGT)

Share Price is delayed by 15 minutes
Get Live Data
254.50    -6.00 (-2.30%)
Bid:
254.50
Ask:
255.50
Spread: 1.00 (0.393%)
Market Cap: £1.01b
AGT Live PriceLast checked at - London Stock Exchange

Intraday AVI Global Trust Share Chart

Monthly Update

11 Jun 2024 13:26

RNS Number : 0065S
AVI Global Trust PLC
11 June 2024
 

 

AVI GLOBAL TRUST PLC

 

Monthly Update

 

AVI Global Trust plc (the "Company") presents its Update, reporting performance figures for the month ended 31 May 2024.

 

This Monthly Newsletter is available on the Company's website at:

https://www.assetvalueinvestors.com/content/uploads/2024/06/AGT-MAY-2024.pdf

 

Performance Total Return

 

This investment management report relates to performance figures to 31 May 2024.

 

Total

Return (£)

Month

Calendar Yr

to date

1Y

3Y

5Y

10Y

AGT NAV

2.5%

8.6%

27.2%

32.3%

77.0%

172.2%

MSCI ACWI

2.3%

9.0%

20.3%

29.7%

72.0%

195.1%

MSCI ACWI ex US

1.2%

5.9%

13.6%

12.6%

37.6%

95.5%

 

Manager's Comment

 

AVI Global Trust (AGT)'s NAV increased +2.5% in May

 

News Corp was the top contributor over the month, adding +92bps as the shares rose +14%, benefitting from both NAV growth (+8%) and narrowing of the discount (to 39% from 42%). Schibsted and Oakley were also meaningful contributors adding +51bps and +35bps apiece.

 

Entain was the weakest performer, shaving - 43bps off NAV as the shares have continued to underperform since we wrote it up in the February newsletter. We provide a short update on the position below.

 

Further to last month's newsletter, during May we completed the sale of our position in Hipgnosis. This generated proceeds of £91m. We have been redeploying this into a number of new positions which we will discuss in future letters. Although discounts have generally narrowed as equity markets have rallied since October 2023, we continue to find a wide variety of interesting opportunities across all parts of our universe. We keep this month's newsletter relatively short (and hopefully sweet) and look forward to updating you on portfolio activity in the near future.

 

Entain

 

Entain was the most significant detractor, with the shares declining -14% in May. During the month the company's capital allocation committee provided an update to the market. For investors expecting major asset sales or changes this was something of a damp squib, with Crystal Bet in Georgia the only asset to be sold. We believe patience is needed as steps taken over the last year start to pay off, and that improved fundamentals - both for Entain's wholly owned assets and at BetMGM - will open up numerous paths to unlock and grow value. Other investors are seemingly losing patience, and we have been modestly adding to the position. We note that several board members have been buying shares in the market and like our alignment of interest with several thoughtful and engaged shareholders.

 

KKR

 

During the month we exited the position in KKR. Since the position entered the portfolio in 2020, it has been a very strong source of returns for AGT. Our thesis was simple: that the listed alternative asset management sector was systematically undervalued, and that KKR (and Apollo, which we also own) was itself undervalued relative to peers.

 

The market perception of alternative asset managers was - and to an extent still is - that they are high beta plays on risk assets. While we concede that both KKR and Apollo have more on-balance sheet risk than peers, our contention was that the market underestimates the defensive characteristics of scale-advantaged managers that earn fees on long-dated committed capital, and the powerful tailwinds for structural growth across the industry. Evidence for this has been borne out in results and was clearly articulated at the recent investor day we attended in New York City in April.

 

Over time the market has come closer to our way of thinking and the shares have re-rated significantly to reflect the company's attractive long-term growth prospects. Over the course of the investment, KKR generated an ROI of +217% and an IRR of +59%, which compares to returns of +40% and +14% for the MSCI AC World Index (all in GBP).

 

Contributors / Detractors (in GBP)

 

Largest Contributors

1- month contribution

bps

% Weight

News Corp

93

8.8

Schibsted ASA 'B'

51

2.3

Oakley Capital Investments

36

6.7

Nihon Kohden

26

2.9

Princess Private Equity

25

5.6

 

Largest Detractors

1- month contribution

bps

% Weight

Entain

-43

2.5

Symphony International Holdings

-26

2.0

Hipgnosis Songs

-20

0.0

FEMSA

-18

4.1

Kyocera Corp

-13

1.3

 

 

Link Company Matters Limited

Corporate Secretary

 

11 June 2024

 

LEI: 213800QUODCLWWRVI968

 

The content of the Company's web-pages and the content of any website or pages which may be accessed through hyperlinks on the Company's web-pages, other than the content of the Newsletter referred to above, is neither incorporated into nor forms part of the above announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCFLFFFRVILLIS
Date   Source Headline
5th Feb 202612:13 pmRNSNet Asset Value(s)
4th Feb 202612:46 pmRNSNet Asset Value(s)
3rd Feb 20265:28 pmRNSTransaction in Own Shares
3rd Feb 20265:28 pmRNSAGM results: update statement
3rd Feb 202612:28 pmRNSNet Asset Value(s)
2nd Feb 202612:22 pmRNSNet Asset Value(s)
2nd Feb 202611:11 amRNSTotal Voting Rights
30th Jan 20261:25 pmRNSNet Asset Value(s)
29th Jan 20265:37 pmRNSTransaction in Own Shares
29th Jan 20261:50 pmRNSNet Asset Value(s)
28th Jan 20265:21 pmRNSTransaction in Own Shares
28th Jan 20261:36 pmRNSNet Asset Value(s)
27th Jan 20261:18 pmRNSNet Asset Value(s)
26th Jan 202612:03 pmRNSNet Asset Value(s)
23rd Jan 20265:06 pmRNSTransaction in Own Shares
23rd Jan 202612:56 pmRNSNet Asset Value(s)
23rd Jan 20267:00 amRNS-RAVI Open Letter to HVPE Board, Manager, Shareh’drs
22nd Jan 202612:42 pmRNSNet Asset Value(s)
21st Jan 20261:23 pmRNSNet Asset Value(s)
20th Jan 20265:12 pmRNSTransaction in Own Shares
20th Jan 202612:42 pmRNSNet Asset Value(s)
19th Jan 20261:04 pmRNSNet Asset Value(s)
16th Jan 20261:40 pmRNSNet Asset Value(s)
15th Jan 20265:15 pmRNSTransaction in Own Shares
15th Jan 20261:50 pmRNSNet Asset Value(s)
14th Jan 20265:16 pmRNSTransaction in Own Shares
14th Jan 202612:05 pmRNSNet Asset Value(s)
13th Jan 20265:26 pmRNSTransaction in Own Shares
13th Jan 20265:02 pmRNSMonthly Factsheet
13th Jan 202612:33 pmRNSNet Asset Value(s)
12th Jan 20263:21 pmRNSNet Asset Value(s)
9th Jan 202611:35 amRNSNet Asset Value(s)
8th Jan 202612:09 pmRNSNet Asset Value(s)
7th Jan 202612:54 pmRNSNet Asset Value(s)
7th Jan 202612:27 pmRNSListing Rule 15.6.8
6th Jan 20265:22 pmRNSTransaction in Own Shares
6th Jan 202612:48 pmRNSNet Asset Value(s)
5th Jan 202612:54 pmRNSNet Asset Value(s)
2nd Jan 202611:58 amRNSNet Asset Value(s)
31st Dec 202510:59 amRNSNet Asset Value(s)
30th Dec 202512:11 pmRNSNet Asset Value(s)
29th Dec 202511:59 amRNSNet Asset Value(s)
24th Dec 202511:42 amRNSNet Asset Value(s)
23rd Dec 20252:15 pmRNSNet Asset Value(s)
22nd Dec 20251:08 pmRNSNet Asset Value(s)
19th Dec 20252:57 pmRNSResult of AGM
19th Dec 20252:57 pmRNSResult of AGM
19th Dec 20251:21 pmRNSNet Asset Value(s)
18th Dec 202511:35 amRNSNet Asset Value(s)
17th Dec 202512:18 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.